Stomach Cancer

The goal of cancer immunotherapy is to improve the body natural ability to find and destroy cancer cells. Successful immunotherapeutic approaches stimulate the natural defenses of the immune system and provide new ways to attack cancer. This is possible with comprehensive interventions that include cell therapy / immuno-pharmacological therapy in combination with nutritional, endocrine measures and supplements.

Cancer vaccines deliver a cancer-specific protein to the body and direct the immune system to target cells that contain that protein.
Chimeric antigen receptor (CAR)-modified T-cell immunotherapy involves taking the patient’s Tcells, genetically engineering the T cells to produce receptors that direct them to the cancer cells, and returning these CAR T cells to the patient’s body (NCI 2017b).

T-cell Modulators are peptide chains composed of tens of amino acids that appear to store all the experience of the immune system. The great intellectual leap to understand is that T-cell Modulators do not transfer antibodies nor create them directly, but its function is to educate, and teach the immune cells to recognize specific antigens that could happen to them unnoticed T-cell Modulators do not cure anything but work to make a “smarter” immune system so that it is the body itself eliminating disease. They are therefore vital in developing the strategies of the immune system against cancer.
T-cell Modulators contains several immunoactive components that have been shown to act synergistically in raising Dendritic and NK function.

Hyperthermia involves the use of heat to directly treat a tumor or increase the vulnerability of cancer cells to other forms of treatment, such as immunotherapy, B17, vitamin C, chemotherapy or radiotherapy.

Non-ablative or mild hyperthermia (HT) has been shown in preclinical and clinical studies as a localized sensitizer that enhances the tumoricidal effects of immunotherapy, radiation or chemotherapy.

A novel, minimally invasive interventional technique, HT has been shown to improve the efficacy of chemotherapy and immunotherapy for solid organ tumors.

Mistletoe helps fight tumor-induced immune suppression. Natural killer cells (NK) are a type of white blood cell that looks for and destroys cancer cells. Studies show that it activates natural killer cells, T cells, macrophages and monocytes.

A study involving 220 cancer patients showed that those given mistletoe experienced less fatigue, insomnia, anorexia, and nausea. For stomach cancer, adding mistletoe to an oral chemotherapy regimen may also be beneficial.

Glutathione is the most important antioxidant produced by your body and a master detoxifier of every cell in your body. It prevents cellular damage caused by free radicals and peroxides.

Glutathione metabolism can play both protective and pathogenic roles. It is crucial in the removal and detoxification of carcinogens, and alterations in this pathway can have a profound effect on cell survival. However, by conferring resistance to several chemotherapeutic drugs, elevated levels of glutathione in tumor cells can protect such cells.

Background and Objectives Vitamin D deficiency is linked to several gastrointestinal malignancies including gastric cancer and affects a multitude of cellular processes involved in tumorigenesis.

Vitamin D, extensive literature demonstrates its action as a preventive agent and treatment of immunological abnormalities.

Melatonin, a hormone best known for its role in regulating sleep, is also emerging as a promising anti-cancer agent. Evidence to date has shown that melatonin can interfere with cancer initiation, progression, and metastasis.

Melatonin Inhibits the Proliferation of Gastric Cancer Cells Through Regulating the miR-16-5p-Smad3 Pathway.